key: cord-0733186-ocb1tlzp
authors: Quispe Flores, María Alejandra; Concepción Zavaleta, Marcio José; Plasencia Dueñas, Esteban Alberto; Lam, Mikaela Kcomt
title: The COVID-19 pandemic in developing countries: A new opportunity to improve the monitoring of patients with diabetes mellitus
date: 2020-09-22
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2020.09.023
sha: a87f5bbaaa034fe69de7e8fa600205bf94666389
doc_id: 733186
cord_uid: ocb1tlzp

nan

The narrative review published by Macherera et al 1 has been of great interest to us, as it highlights the importance of establishing a personalized educational plan in patients with diabetes during the COVID-19 pandemic, based on preventive measures, medications, changes in lifestyle, self-monitoring of glucose, foot care and prevention of complications. This is something that we are also currently doing in Peru, which to date is the country with the highest mortality rate from COVID-19 in the world, taking into account the number of inhabitants 2 .

The COVID-19 pandemic has taught us many lessons, including that diabetic patients have a higher risk of mortality and of developing severe course of disease 3 . In this context, maintaining adequate metabolic control of diabetic patients is of extreme importance 4 .

However, circumstances such as confinement, closure of outpatient clinics, and the fear of contracting SARS-CoV-2 result in less access to healthcare services.

Under these circumstances, it is essential for us to adapt our medical practice and find ways that allow us to provide the necessary care to our patients. A very interesting alternative is telemedicine. In 2018 and 2019, two meta-analyses of controlled clinical trials were carried out with the aim of comparing the results of telemedicine and the usual care for diabetic patients. Both studies found a greater reduction in glycated hemoglobin (HbA1c) in the telemedicine group, especially in older patients with type 2 diabetes with a HbA1c > 9% and when performing more frequent interventions (at least 6 times a year) 5,6 .

In our clinical practice, in the Endocrinology department of a Peruvian national hospital, we have created a monitoring sheet that is delivered to our patients upon discharge (Table   1) , allowing patient follow-up with good results so far. The use of this tool has gained acceptance in our patients, particularly during this time, greatly facilitating their interaction J o u r n a l P r e -p r o o f with medical personnel and giving them a sense of security and empathy. With a single picture of the file, healthcare professionals can provide counseling and treatment adjustments. Additionally, patients can record their progress and goals, thus increasing their commitment and adherence.

In conclusion, we highlight that although Peru is one of the countries that is suffering the most from the consequences of the COVID-19 pandemic, this may be an opportunity to discover tools to improve the control of patients with diabetes and contribute to overcoming barriers to the access of health services. 

Self-management of diabetes mellitus during the Covid-19 pandemic: Recommendations for a resource limited setting

Casos confirmados y mortalidad por COVID-19 en Sudamérica: un análisis comparativo por millón de habitantes

COVID-19 in people living with diabetes: An international consensus

Management of diabetes mellitus in the era of COVID-19

Evaluation of the clinical outcomes of telehealth for managing diabetes

Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of

The authors declare no conflict of interest in this publication.

The authors received no funding from an external source.J o u r n a l P r e -p r o o f